Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALGANCICLOVIR Cause Condition aggravated? 132 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Condition aggravated have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 1.7% of all adverse event reports for VALGANCICLOVIR.

132
Reports of Condition aggravated with VALGANCICLOVIR
1.7%
of all VALGANCICLOVIR reports
27
Deaths
77
Hospitalizations

How Dangerous Is Condition aggravated From VALGANCICLOVIR?

Of the 132 reports, 27 (20.5%) resulted in death, 77 (58.3%) required hospitalization, and 6 (4.5%) were considered life-threatening.

Is Condition aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 132 reports have been filed with the FAERS database.

What Other Side Effects Does VALGANCICLOVIR Cause?

Off label use (1,882) Cytomegalovirus infection (1,091) Drug ineffective (886) Neutropenia (809) Leukopenia (574) Drug resistance (524) Cytomegalovirus viraemia (447) Pancytopenia (434) Cytomegalovirus infection reactivation (374) Death (359)

What Other Drugs Cause Condition aggravated?

TOFACITINIB (16,925) INFLIXIMAB (16,616) DUPILUMAB (16,459) ETANERCEPT (15,897) METHOTREXATE (14,938) ADALIMUMAB (13,527) PREDNISONE (10,751) INFLIXIMAB-DYYB (10,275) HYDROXYCHLOROQUINE (8,848) RITUXIMAB (8,627)

Which VALGANCICLOVIR Alternatives Have Lower Condition aggravated Risk?

VALGANCICLOVIR vs VALIUM VALGANCICLOVIR vs VALPROATE VALGANCICLOVIR vs VALPROIC ACID VALGANCICLOVIR vs VALPROMIDE VALGANCICLOVIR vs VALSARTAN

Related Pages

VALGANCICLOVIR Full Profile All Condition aggravated Reports All Drugs Causing Condition aggravated VALGANCICLOVIR Demographics